Imaxeon Research and Development

Imaxeon’s development team has been responsible for 4 generations of contrast injectors, starting with the PJ series of CT injectors which coupled low pricing with ease of use. Subsequent generations include an angio injector and more recently the Salient CT Injector

The internal development processes are audited annually for compliance with ISO13485, and are appropriate to Class IIa, IIb and lower risk medical devices. Imaxeon has also developed several successful syringe lines to accompany these injectors. The cross-disciplinary team is small but able to focus on delivering cohesive value-appropriate solutions to meet the needs of global markets.